Intra- and extra-hospital improvement in ischemic stroke patients: influence of reperfusion therapy and molecular mechanisms

[1]  B. Engelhardt,et al.  Ischemia–reperfusion injury in stroke: impact of the brain barriers and brain immune privilege on neutrophil function , 2018, Therapeutic advances in neurological disorders.

[2]  J. Montaner,et al.  Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management , 2018, Therapeutic advances in neurological disorders.

[3]  W. Feng,et al.  Long-term outcomes of acute ischemic stroke patients treated with endovascular thrombectomy: A real-world experience , 2018, Journal of the Neurological Sciences.

[4]  Á. Chamorro.  Neuroprotectants in the Era of Reperfusion Therapy , 2018, Journal of stroke.

[5]  C. Wolfe,et al.  Long-Term Survival After Intravenous Thrombolysis for Ischemic Stroke , 2018, Stroke.

[6]  Geoffrey A. Donnan,et al.  Endovascular Thrombectomy for Ischemic Stroke Increases Disability-Free Survival, Quality of Life, and Life Expectancy and Reduces Cost , 2017, Front. Neurol..

[7]  J. Baron,et al.  Reconsidering Neuroprotection in the Reperfusion Era , 2017, Stroke.

[8]  T. Sobrino,et al.  Worse Outcome in Stroke Patients Treated with rt-PA Without Early Reperfusion: Associated Factors , 2017, Translational Stroke Research.

[9]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[10]  K. Lambertsen,et al.  Beneficial potential of intravenously administered IL-6 in improving outcome after murine experimental stroke , 2017, Brain, Behavior, and Immunity.

[11]  Xiujuan Zhao,et al.  Neuroprotective effects of sulfiredoxin-1 during cerebral ischemia/reperfusion oxidative stress injury in rats , 2017, Brain Research Bulletin.

[12]  Á. Chamorro,et al.  Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation , 2016, The Lancet Neurology.

[13]  T. Sobrino,et al.  Influence of the separation procedure on the properties of magnetic nanoparticles: Gaining in vitro stability and T1-T2 magnetic resonance imaging performance. , 2016, Journal of colloid and interface science.

[14]  P. Lyden,et al.  Revisiting Cerebral Postischemic Reperfusion Injury: New Insights in Understanding Reperfusion Failure, Hemorrhage, and Edema , 2015, International journal of stroke : official journal of the International Stroke Society.

[15]  C. Sudlow,et al.  Prognostic value of blood interleukin-6 in the prediction of functional outcome after stroke: A systematic review and meta-analysis , 2014, Journal of Neuroimmunology.

[16]  V. Janardhan,et al.  Blood–brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke , 2012, Neurology.

[17]  Ken Arai,et al.  Pathophysiologic Cascades in Ischemic Stroke , 2012, International journal of stroke : official journal of the International Stroke Society.

[18]  T. Eckle,et al.  Ischemia and reperfusion—from mechanism to translation , 2011, Nature Medicine.

[19]  K. Schaller,et al.  Recombinant tissue plasminogen activator induces blood–brain barrier breakdown by a matrix metalloproteinase‐9‐independent pathway after transient focal cerebral ischemia in mouse , 2011, The European journal of neuroscience.

[20]  L. Soinne,et al.  Association of Early National Institutes of Health Stroke Scale Improvement With Vessel Recanalization and Functional Outcome After Intravenous Thrombolysis in Ischemic Stroke , 2011, Stroke.

[21]  C. Iadecola,et al.  The immunology of stroke: from mechanisms to translation , 2011, Nature Medicine.

[22]  Eng H. Lo,et al.  The Science of Stroke: Mechanisms in Search of Treatments , 2010, Neuron.

[23]  M. Wintermark,et al.  Reperfusion Is a More Accurate Predictor of Follow-Up Infarct Volume Than Recanalization: A Proof of Concept Using CT in Acute Ischemic Stroke Patients , 2010, Stroke.

[24]  S. Lakhan,et al.  Inflammatory mechanisms in ischemic stroke: therapeutic approaches , 2009, Journal of Translational Medicine.

[25]  M. Vangel,et al.  ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes , 2009, Neurology.

[26]  C. Molina,et al.  Temporal Profile of Recanalization After Intravenous Tissue Plasminogen Activator: Selecting Patients for Rescue Reperfusion Techniques , 2006, Stroke.

[27]  E. Connolly,et al.  Anti-adhesion molecule strategies as potential neuroprotective agents in cerebral ischemia: A critical review of the literature , 2004, Inflammation Research.

[28]  Á. Chamorro,et al.  Levels of Anti-Inflammatory Cytokines and Neurological Worsening in Acute Ischemic Stroke , 2003, Stroke.

[29]  C. Ikonomidou,et al.  Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? , 2002, The Lancet Neurology.

[30]  Á. Chamorro,et al.  Proinflammatory Cytokines and Early Neurological Worsening in Ischemic Stroke , 2000, Stroke.

[31]  A. Dávalos,et al.  Progression of ischaemic stroke and excitotoxic aminoacids , 1997, The Lancet.

[32]  A. Dávalos,et al.  Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. , 1996, Stroke.

[33]  C. Epstein,et al.  Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[34]  T. Pekmezović,et al.  Long-Term Prognosis in Ischemic Stroke Patients Treated with Intravenous Thrombolytic Therapy. , 2017, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[35]  D. Scheinert.  Real-World Experience , 2014 .

[36]  Peter Angura.  WHAT ARE THE ASSOCIATED FACTORS ? , 2013 .

[37]  Janice K Popp,et al.  MMBA 8109: Research Methods Critical Review of Literature , 2012 .

[38]  C. Goetz,et al.  Therapeutic approaches. , 2000, Advances in neurology.

[39]  J. Fry,et al.  An evaluation of the Waters Pico-Tag system for the amino-acid analysis of food materials , 1986, The Journal of automatic chemistry.